A New Tool to Assess the Epidemiology of Immune Thrombocytopenia: The Nordic Country Patient Registry for Romiplostim

EClinicalMedicine - United Kingdom
doi 10.1016/j.eclinm.2019.08.011
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Highly Fluctuating Thrombocytopenia Developing in a Patient With Immune Thrombocytopenia (ITP) While Administering Romiplostim

Internal Medicine
Internal MedicineMedicine
2012English

Romiplostim for the Management of Perioperative Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Romiplostim as Early Treatment of Immune Thrombocytopenia With Severe Immunodeficiency

Hematology Reports
Hematology
2012English

Erratum To: Treatment of 5 Dogs With Immune-Mediated Thrombocytopenia Using Romiplostim

BMC Veterinary Research
MedicineVeterinary
2016English

The Efficacy and Safety of Romiplostim in Adult Patients With Chronic Immune Thrombocytopenia

Therapeutic Advances in Hematology
Hematology
2012English

Self-Administration of Romiplostim in Patients With Chronic Immune Thrombocytopenia

Community Oncology
2013English

Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia

American Journal of Hematology
Hematology
2018English

A Single Center Experience With Romiplostim for the Management of Chemotherapy-Induced Thrombocytopenia

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy